AI-generated summary
The authors report a case study of one 60-year-old man with diabetic macular edema treated with 670 nm light photobiomodulation alone. They describe improved vision and resolved edema on optical coherence tomography, with no adverse events and stable results over 16 months of follow-up. As a single-patient case report, the findings cannot establish general effectiveness.
- Who or what was studied
- One 60-year-old man with diabetic macular edema
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The report describes a single patient, so the results cannot be generalized and no comparison group was used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Case report, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.